169 related articles for article (PubMed ID: 16982755)
1. Epigenetic silencing of occludin promotes tumorigenic and metastatic properties of cancer cells via modulations of unique sets of apoptosis-associated genes.
Osanai M; Murata M; Nishikiori N; Chiba H; Kojima T; Sawada N
Cancer Res; 2006 Sep; 66(18):9125-33. PubMed ID: 16982755
[TBL] [Abstract][Full Text] [Related]
2. Occludin-mediated premature senescence is a fail-safe mechanism against tumorigenesis in breast carcinoma cells.
Osanai M; Murata M; Nishikiori N; Chiba H; Kojima T; Sawada N
Cancer Sci; 2007 Jul; 98(7):1027-34. PubMed ID: 17459053
[TBL] [Abstract][Full Text] [Related]
3. Silencing of MBD1 and MeCP2 in prostate-cancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes.
Yaqinuddin A; Abbas F; Naqvi SZ; Bashir MU; Qazi R; Qureshi SA
Biosci Rep; 2008 Dec; 28(6):319-26. PubMed ID: 18666890
[TBL] [Abstract][Full Text] [Related]
4. Tumor prone phenotype of mice deficient in a novel apoptosis-inducing gene, drs.
Tambe Y; Yoshioka-Yamashita A; Mukaisho K; Haraguchi S; Chano T; Isono T; Kawai T; Suzuki Y; Kushima R; Hattori T; Goto M; Yamada S; Kiso M; Saga Y; Inoue H
Carcinogenesis; 2007 Apr; 28(4):777-84. PubMed ID: 17088259
[TBL] [Abstract][Full Text] [Related]
5. SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway.
Chung MT; Lai HC; Sytwu HK; Yan MD; Shih YL; Chang CC; Yu MH; Liu HS; Chu DW; Lin YW
Gynecol Oncol; 2009 Mar; 112(3):646-53. PubMed ID: 19095296
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of survival signaling through MAPK and Akt in occludin-deficient mouse hepatocytes in vitro.
Murata M; Kojima T; Yamamoto T; Go M; Takano K; Osanai M; Chiba H; Sawada N
Exp Cell Res; 2005 Oct; 310(1):140-51. PubMed ID: 16112666
[TBL] [Abstract][Full Text] [Related]
7. A novel splice variant of occludin deleted in exon 9 and its role in cell apoptosis and invasion.
Gu JM; Lim SO; Park YM; Jung G
FEBS J; 2008 Jun; 275(12):3145-56. PubMed ID: 18489585
[TBL] [Abstract][Full Text] [Related]
8. A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition.
Pampalakis G; Prosnikli E; Agalioti T; Vlahou A; Zoumpourlis V; Sotiropoulou G
Cancer Res; 2009 May; 69(9):3779-87. PubMed ID: 19383923
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
10. Suppression of tumorigenicity, but not anchorage independence, of human cancer cells by new candidate tumor suppressor gene CapG.
Watari A; Takaki K; Higashiyama S; Li Y; Satomi Y; Takao T; Tanemura A; Yamaguchi Y; Katayama I; Shimakage M; Miyashiro I; Takami K; Kodama K; Yutsudo M
Oncogene; 2006 Nov; 25(56):7373-80. PubMed ID: 16767159
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic silencing of O6-methylguanine DNA methyltransferase gene in NiS-transformed cells.
Ji W; Yang L; Yu L; Yuan J; Hu D; Zhang W; Yang J; Pang Y; Li W; Lu J; Fu J; Chen J; Lin Z; Chen W; Zhuang Z
Carcinogenesis; 2008 Jun; 29(6):1267-75. PubMed ID: 18204074
[TBL] [Abstract][Full Text] [Related]
12. Glioma pathogenesis-related protein 1 exerts tumor suppressor activities through proapoptotic reactive oxygen species-c-Jun-NH2 kinase signaling.
Li L; Abdel Fattah E; Cao G; Ren C; Yang G; Goltsov AA; Chinault AC; Cai WW; Timme TL; Thompson TC
Cancer Res; 2008 Jan; 68(2):434-43. PubMed ID: 18199537
[TBL] [Abstract][Full Text] [Related]
13. The apoptosis-inducing effect of gastrin on colorectal cancer cells relates to an increased IEX-1 expression mediating NF-kappa B inhibition.
Sebens Müerköster S; Rausch AV; Isberner A; Minkenberg J; Blaszczuk E; Witt M; Fölsch UR; Schmitz F; Schäfer H; Arlt A
Oncogene; 2008 Feb; 27(8):1122-34. PubMed ID: 17704804
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y
J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792
[TBL] [Abstract][Full Text] [Related]
15. CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis.
Wang Y; Li J; Cui Y; Li T; Ng KM; Geng H; Li H; Shu XS; Li H; Liu W; Luo B; Zhang Q; Mok TS; Zheng W; Qiu X; Srivastava G; Yu J; Sung JJ; Chan AT; Ma D; Tao Q; Han W
Cancer Res; 2009 Jun; 69(12):5194-201. PubMed ID: 19509237
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of survival-related gene, a novel cell survival gene controlling apoptosis and tumorigenesis.
Yuan ZR; Wang R; Solomon J; Luo X; Sun H; Zhang L; Shi Y
Cancer Res; 2005 Dec; 65(23):10716-24. PubMed ID: 16322216
[TBL] [Abstract][Full Text] [Related]
17. Opposing roles of netrin-1 and the dependence receptor DCC in cancer cell invasion, tumor growth and metastasis.
Rodrigues S; De Wever O; Bruyneel E; Rooney RJ; Gespach C
Oncogene; 2007 Aug; 26(38):5615-25. PubMed ID: 17334389
[TBL] [Abstract][Full Text] [Related]
18. The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis.
Dopeso H; Mateo-Lozano S; Mazzolini R; Rodrigues P; Lagares-Tena L; Ceron J; Romero J; Esteves M; Landolfi S; Hernández-Losa J; Castaño J; Wilson AJ; Ramon y Cajal S; Mariadason JM; Schwartz S; Arango D
Cancer Res; 2009 Sep; 69(18):7430-8. PubMed ID: 19738063
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic silencing of claudin-6 promotes anchorage-independent growth of breast carcinoma cells.
Osanai M; Murata M; Chiba H; Kojima T; Sawada N
Cancer Sci; 2007 Oct; 98(10):1557-62. PubMed ID: 17645772
[TBL] [Abstract][Full Text] [Related]
20. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
